GCG and diabetes mellitus: By identifying <i>β</i>-cell loss as the primary driver of impaired glucagon secretion, this work reframes counterregulatory dysfunction as an islet network defect and highlights restoration of intra-islet <i>β</i>-cell signaling as a therapeutic strategy for improving glycemic stability in diabetes.